Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium channel (KATP channel) in pancreatic beta cells is a crucial molecular complex that links cellular metabolism to electrical activity, thereby regulating insulin secretion. It acts as a metabolic sensor, responding to changes in intracellular ATP and ADP levels, and plays a central role in glucose-stimulated insulin release. The KATP channel is a hetero-octameric protein complex composed of four pore-forming Kir6.2 subunits (encoded by the KCNJ11 gene) and four regulatory sulfonylurea receptor 1 (SUR1) subunits (encoded by the ABCC8 gene). Mutations in these genes can cause neonatal diabetes mellitus or congenital hyperinsulinism.
Sulfonylureas bind to SUR1 and close the KATP channel independently of intracellular ATP/ADP ratios, stimulating insulin release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-Sensitive Potassium Channel in Pancreatic Beta Cells (KATP channel).